{"id":"NCT02800148","sponsor":"Padagis LLC","briefTitle":"Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face","officialTitle":null,"status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-11","primaryCompletion":"2017-10","completion":"2017-10","firstPosted":"2016-06-15","resultsPosted":"2020-12-09","lastUpdate":"2021-11-08"},"enrollment":667,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Rosacea"],"interventions":[{"type":"DRUG","name":"Azelaic acid foam","otherNames":[]},{"type":"DRUG","name":"Azelaic acid foam","otherNames":["Finacea Foam"]},{"type":"DRUG","name":"Azelaic acid foam - Placebo","otherNames":[]}],"arms":[{"label":"Azelaic acid foam","type":"EXPERIMENTAL"},{"label":"Finacea Foam","type":"ACTIVE_COMPARATOR"},{"label":"Placebo Foam","type":"PLACEBO_COMPARATOR"}],"summary":"To compare the bioequivalence of Perrigo's azelaic acid foam product to Finacea Foam for the treatment of Inflammatory Lesions of Rosacea","primaryOutcome":{"measure":"Percent Change (Reduction) of Lesion Count From Day 1","timeFrame":"Day 84","effectByArm":[{"arm":"Azelaic Acid Foam","deltaMin":61.14,"sd":33.623},{"arm":"Finacea Foam","deltaMin":57.27,"sd":34.513},{"arm":"Placebo Foam","deltaMin":49.43,"sd":44.437}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":224},"commonTop":[]}}